As of Feb 03, 2025, Quest Diagnostics Incorporated Intrinsic Value is $375.4. This suggests it may be undervalued by 131.1% compared to its current price of around $162.5.
As of Feb 03, 2025, Quest Diagnostics Incorporated's Discounted Cash Flow (DCF) valuation estimates its share price at $332.4. This suggests it may be overvalued by 104.6% to its current price of around $162.5, using a discount rate of 5.9% and terminal growth rate of 3.0%.
Quest Diagnostics Incorporated is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $375.4, compared to a market price of around $162.5. This suggests a potential undervaluation of 131.1%.